ALN-PCS01 - Alnylam, Novartis
Alnylam Pharmaceuticals: Q2 2015 Results (Alnylam) - Aug 9, 2015 - Anticipated presentation of initial data from P1 trial in hypercholesterolemia at ESC (Aug 30, 2015) 
Anticipated P1 data • Dyslipidemia
http://seekingalpha.com/article/3412606-alnylam-pharmaceuticals-alny-john-m-maraganore-on-q2-2015-results-earnings-call-transcript
 
Aug 9, 2015
 
.